CD8A and neoplasm: As CD8+ T cells are central to tumor killing, and the anti-tumor immunity of CD8+ T cells was inhibited by the expression of PD-L1 in the tumor microenvironment38, we assess the infiltration and function of the CD8+ T cells in two syngeneic tumor models of both B16/F10 and MC38 tumor cells.